Delivery Order SPE2DR25D3004-SPE2DR26FXTZ7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,108.70. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $3,267.60 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, indicating it was issued under an existing indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $1,115.57, with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens with a ceiling value of $2,777.51 under a firm fixed-price arrangement. The contract, which was competitively awarded with no set-aside designation, was finalized on December 8, 2025, with an ultimate completion date of December 9, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,537.84 firm fixed price delivery order on July 29, 2025, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 30, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens with a ceiling value of $1,636.80. The contract was competitively awarded without set-aside designation and is classified as a Firm Fixed Price delivery order, with an ultimate completion date of October 27, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,177.92. The award was made on December 9, 2025, with an ultimate completion date of December 10, 2025, under a firm fixed price contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $3,732.06, with an ultimate completion date of November 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,020.90 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on December 9, 2025, with completion scheduled for December 10, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its...
- The Defense Logistics Agency awarded a $1,020.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on January 15, 2026, with completion scheduled for January 16, 2026. The award was made on a non-set-aside, competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, significantly larger indefinite delivery...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXTZ7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/ml FlexPen 3ml insulin pens, with a contract ceiling value of $1,434.47 and an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a routine pharmaceutical supply transaction under the company's broader federal medical contracting portfolio. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031. This comprehensive IDC vehicle enables the pharmaceutical distributor to supply a broad range of medications, medical devices, vaccines, and specialized healthcare commodities to support military treatment facilities and other federal healthcare systems globally. AmerisourceBergen's extensive federal contracting history and competitive positioning as a major pharmaceutical distributor make it a critical vendor for military and veterans' healthcare procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/13/26 |